ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 303861 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 303861; 2) Community: the network communities that were significantly associated with the response to NSC 303861; 3) Molecule: the relationships between components within communities and NSC 303861; 4) MDR: the compounds that were significantly associated with the NSC 303861.

NSC Compound Enrichment Correlation
NSC 81206 Null 0.0395466756030208 0.38739672
NSC 278619 L-Arabinose, 2-amino-4-[(2-amino-1-oxopropyl)amino]-2,4-dideoxy-, monohydrochloride 0.0396077140933374 -0.24089405
NSC 352122 Trimetrexate glucuronate 0.0396077140933377 0.36629584
NSC 603086 2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (Z)- 0.0396077140933377 0.64511541
NSC 605440 Isothiazolo[2,3-a]azepine, 5,7-bis(trifluoromethyl)- 2,3-dihydro-, 1,1-dioxide 0.0396077140933377 0.6421876
NSC 613011 Latrunculin A 0.0396077140933377 -0.21245899
NSC 617823 4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride 0.0396077140933377 0.72092773
NSC 619102 4-Methoxy-1,5-benzothiazepine-1,1-dioxide 0.0396077140933377 0.46576148
NSC 623639 Cyclopentane-1,3-dimethanamine, N,N,N,N',N',N'-hexamethyl-2-oxo-, iodide 0.0396077140933377 0.59739472
NSC 624172 Null 0.0396077140933377 0.4190928
Total:80  Current:68    [First] [Prev] [Next] [Last]